Ripple's regulated dollar stablecoin RLUSD recently reached a record circulating supply of about $2.44 billion, with most new tokens issued since July landing on Ethereum rather than Ripple's own XRP Ledger (XRPL). Launched on both chains under a New York trust charter, RLUSD was designed to use XRPL for fast, low-cost payments and Ethereum for deep DeFi liquidity. While XRPL briefly caught up in mid-2026, Ethereum now holds about 56.5% of RLUSD supply, driven by strong DeFi demand and institutional holdings. Ripple manages liquidity across both chains but the majority of recent growth favors Ethereum, raising questions about XRPL's future dominance as payment volumes scale. RLUSD continues expanding toward corporate treasury use and additional networks, highlighting its growing market presence despite the split.
Ripple's stablecoin RLUSD surpassing $2.44 billion in circulating supply sets a notable context for this report. For readers following cryptocurrency markets, here is Pluang's snapshot as of Sep 15, 2026 07:21 WIB: among 50 major cryptocurrencies, 33 rose and 16 fell today. Notable movers include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% at Rp16.297 with 85 days hold, and XLM (Stellar) up 8.50% at Rp3.395 with a 41% sell / 59% buy order activity and 83 days hold time.
Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...
Air Canada will begin a new seasonal nonstop flight service between Montreal and Seville, Spain, starting September 8, 2027. This route is the only nonstop connection between North America and Seville, enhancing travel options for leisure and busines...
Air Canada announced it will start non-stop seasonal flights between Montréal and Seville, Spain, beginning September 8, 2027. This new route is the only direct connection between North America and Seville, enhancing travel options for Canadians and ...
CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...
Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...
